Orange Book product · Brand (NDA)
OXTELLAR XR
OXCARBAZEPINE
At a glance
Oct 19, 2012
Approved
Brand (NDA)
Application
AB
TE code
11
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 19, 2012
13 yr 10 mo ago
Today
Patent 10220042 expires
Listed method-of-use patent (U-2501) expiration.
Apr 13, 2027
in 10 mo
Patent 11166960 expires
Listed drug product patent expiration.
Apr 13, 2027
in 10 mo
Patent 11896599 expires
Listed drug product patent expiration.
Apr 13, 2027
in 10 mo
Patent 7722898 expires
Listed drug product patent expiration.
Apr 13, 2027
in 10 mo
Patent 7910131 expires
Listed method-of-use patent (U-2041) expiration.
Apr 13, 2027
in 10 mo
Patent 8617600 expires
Listed drug product patent expiration.
Apr 13, 2027
in 10 mo
Patent 8821930 expires
Listed drug product patent expiration.
Apr 13, 2027
in 10 mo
Patent 9119791 expires
Listed method-of-use patent (U-2041) expiration.
Apr 13, 2027
in 10 mo
Patent 9351975 expires
Listed drug product patent expiration.
Apr 13, 2027
in 10 mo
Patent 9370525 expires
Listed drug product patent expiration.
Apr 13, 2027
in 10 mo
Patent 9855278 expires
Listed drug product patent expiration.
Apr 13, 2027
in 10 mo
Pharmaceutical detail
Active ingredient
OXCARBAZEPINE
Strength
150MG
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
TE code
AB
Application
NDA 202810
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2001TRILEPTALBrand (NDA)
NDA 021285 · NOVARTIS
- 2000TRILEPTALBrand (NDA)
NDA 021014 · NOVARTIS
- 2026OXCARBAZEPINEGeneric (ANDA)
ANDA 209020 · MSN
- 2026OXCARBAZEPINEGeneric (ANDA)
ANDA 218341 · UMEDICA LABS PVT
- 2026OXCARBAZEPINEGeneric (ANDA)
ANDA 220281 · STERANCO HLTHCARE
- 2026OXCARBAZEPINEGeneric (ANDA)
ANDA 219556 · EPIC PHARMA LLC
- 2025OXCARBAZEPINEGeneric (ANDA)
ANDA 207300 · MACLEODS PHARMS LTD
- 2025OXCARBAZEPINEGeneric (ANDA)
ANDA 219241 · AUROBINDO PHARMA LTD
- 2024OXCARBAZEPINEGeneric (ANDA)
ANDA 215796 · RICONPHARMA LLC
- 2024OXCARBAZEPINEGeneric (ANDA)
ANDA 207717 · RUBICON RESEARCH
- 2024OXCARBAZEPINEGeneric (ANDA)
ANDA 218278 · BIOCON PHARMA
- 2024OXCARBAZEPINEGeneric (ANDA)
ANDA 217659 · AJANTA PHARMA LTD
Listed patents (11)
| Patent | Expires | In | Type |
|---|---|---|---|
| 10220042 | Apr 13, 2027 | in 10 mo | U-2501 |
| 11166960 | Apr 13, 2027 | in 10 mo | Product |
| 11896599 | Apr 13, 2027 | in 10 mo | Product |
| 7722898 | Apr 13, 2027 | in 10 mo | Product |
| 7910131 | Apr 13, 2027 | in 10 mo | U-2041 |
| 8617600 | Apr 13, 2027 | in 10 mo | Product |
| 8821930 | Apr 13, 2027 | in 10 mo | Product |
| 9119791 | Apr 13, 2027 | in 10 mo | U-2041 |
| 9351975 | Apr 13, 2027 | in 10 mo | Product |
| 9370525 | Apr 13, 2027 | in 10 mo | Product |
| 9855278 | Apr 13, 2027 | in 10 mo | Product |
